ATR/CHK1 inhibitors and cancer therapy

Z Qiu, NL Oleinick, J Zhang - Radiotherapy and Oncology, 2018 - Elsevier
The cell cycle checkpoint proteins ataxia-telangiectasia-mutated-and-Rad3-related kinase
(ATR) and its major downstream effector checkpoint kinase 1 (CHK1) prevent the entry of …

Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy

S Vakili-Samiani, OJ Khanghah, E Gholipour… - Mutation Research …, 2022 - Elsevier
Mitosis is the process of cell division and is regulated by checkpoints in the cell cycle. G1-S,
S, and G2-M are the three main checkpoints that prevent initiation of the next phase of the …

DNA damage response-associated cell cycle re-entry and neuronal senescence in brain aging and Alzheimer's disease

GCN Wong, KHM Chow - Journal of Alzheimer's Disease, 2023 - journals.sagepub.com
Chronological aging is by far the strongest risk factor for age-related dementia and
Alzheimer's disease. Senescent cells accumulated in the aging and Alzheimer's disease …

The genetics of congenitally small brains

S Duerinckx, M Abramowicz - Seminars in cell & developmental biology, 2018 - Elsevier
Primary microcephaly (PM) refers to a congenitally small brain, resulting from insufficient
prenatal production of neurons, and serves as a model disease for brain volumic …

ATR Inhibitors in platinum-resistant ovarian cancer

S Li, T Wang, X Fei, M Zhang - Cancers, 2022 - mdpi.com
Simple Summary Platinum-resistant ovarian cancer (PROC) is a deadly cancer with a poor
prognosis. Some drugs targeting ATR have shown initial success in the treatment of PROC …

[HTML][HTML] Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress

Y Zhang, J Lai, Z Du, J Gao, S Yang, S Gorityala… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Radiotherapy (RT) remains a standard therapeutic modality for breast cancer patients.
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …

Targeting lung cancer through inhibition of checkpoint kinases

RG Syljuåsen, G Hasvold, S Hauge, Å Helland - Frontiers in genetics, 2015 - frontiersin.org
Inhibitors of checkpoint kinases ATR, Chk1, and Wee1 are currently being tested in
preclinical and clinical trials. Here, we review the basic principles behind the use of such …

DNA damage as a driver for growth delay: chromosome instability syndromes with intrauterine growth retardation

B García-de Teresa… - BioMed Research …, 2017 - Wiley Online Library
DNA is constantly exposed to endogenous and exogenous mutagenic stimuli that are
capable of producing diverse lesions. In order to protect the integrity of the genetic material …

Transgenic mice harboring direct repeat substrates reveal key underlying causes of homologous recombination in vivo

AC Moise, JE Kay, BP Engelward - DNA repair, 2022 - Elsevier
Homology directed repair is a critical process for maintaining the genome of mammalian
cells. While considered to be relatively error free, homologous recombination (HR) can lead …

Prevalence of homologous recombination biomarkers in multiple tumor types: an observational study

C Chen, EJ Dettman, W Zhou, A Gozman, F Jin… - Future …, 2024 - Taylor & Francis
Aim: To determine the prevalence of deleterious mutations in BRCA1 and BRCA2 and in 13
genes involved in homologous recombination repair (HRR), the prevalence of genomic loss …